(NASDAQ:KURA), SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on October 1, 2025, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards […]
BriaCell to Present Bria-OTS+(TM) Preclinical Data at SITC 2025 Annual Meeting GlobeNewswire October 03, 2025 PHILADELPHIA and VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 5, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET. https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.jpg The live audio webcast can be accessed via Zimmer
NEW YORK CITY, NY / ACCESS Newswire / October 3, 2025 / NEW YORK, NY / ACCESS Newswire / October 3, 2025 / If you suffered a loss on your Snap Inc. (NYSE:SNAP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=170586&wire=1&utm_campaign=13
Azucar Announces TSXV Approval of Option Agreement and Management Changes GlobeNewswire October 03, 2025 VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) — Azucar Minerals Ltd. (“Azucar” or the “Company”) (TSX-V: AMZ; OTCQX: AXDDF) announces that the TSX Venture Exchange has approved the Company's previously announced Option-Joint venture exploration agreement with Almadex Minerals Ltd. (“Almadex”)
Almadex Announces TSXV Approval of Option Agreement and Management Changes GlobeNewswire October 03, 2025 VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) announces that the TSX Venture Exchange has approved the Company's previously announced Option-Joint venture exploration agreement with Azucar Minerals Ltd. (“Azucar”) whereby Azucar
Almaden Announces Management Transition GlobeNewswire October 03, 2025 VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) — Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; OTCQB: AAUAF) is pleased to announce the appointment of Douglas McDonald as President and CEO. Morgan Poliquin has been appointed Vice Chair of the Company. Doug joined Almaden in
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire October 03, 2025 SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on October 1, 2025, the Compensation
NEW YORK CITY, NY / ACCESS Newswire / October 3, 2025 / NEW YORK, NY / ACCESS Newswire / October 3, 2025 / If you suffered a loss on your LifeMD, Inc. (NASDAQ:LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=170569&wire=1&utm_campaign=21
NEW YORK CITY, NY / ACCESS Newswire / October 3, 2025 / NEW YORK, NY / ACCESS Newswire / October 3, 2025 / If you suffered a loss on your Charter Communications, Inc. (NASDAQ:CHTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: